bucladesine has been researched along with nitroglycerin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Berkowitz, BA; Cohen, ML | 2 |
| Gibson, IF; Martin, W; Weir, CJ | 1 |
| Brinker, MR; Cook, SD; Hyman, AL; Lippton, HL | 1 |
| Hoffman, BB; Lee, CH; Tsujimoto, G | 1 |
| Itoh, T; Kanmura, Y; Kuriyama, H; Sasaguri, T | 1 |
| Carretero, OA; Harding, P; LaPointe, MC | 1 |
| Abe, A; Karaki, H | 1 |
| Fujimoto, K; Kawashima, K; Nonaka, H; Suzuki, T | 1 |
| Bando, T; Hirata, T; Kosaka, S; Liu, CJ; Wada, H | 1 |
| Fukuse, T; Hirata, T; Hitomi, S; Inui, K; Kosaka, S; Liu, CJ; Ueda, M; Wada, H; Yokomise, H | 1 |
| Fukuse, T; Hirata, T; Hitomi, S; Liu, CJ; Ueda, Y; Wada, H | 1 |
| Bell, DR; Dec, EM; Rensberger, HJ | 1 |
| Kubo, T; Taguchi, K; Ueda, M | 1 |
| Bando, T; Chen, F; Date, H; Nakajima, D; Ohsumi, A; Sakamoto, J; Yamada, T | 1 |
| Doki, Y; Eguchi, H; Ito, T; Kobayashi, S; Machida, T; Marubashi, S; Mori, M; Nagano, H; Ohmura, Y; Sawa, Y; Tanemura, M; Tanida, T; Wada, H | 1 |
| Ebi, N; Hamada, E; Kinjo, T; Kobayashi, N; Miyagi-Shiohira, C; Nakashima, Y; Noguchi, H; Saitoh, I; Tamaki, Y; Watanabe, M | 1 |
18 other study(ies) available for bucladesine and nitroglycerin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Decreased vascular relaxation in hypertension.
Topics: Adenosine; Animals; Aorta, Thoracic; Bucladesine; Cyclic GMP; Female; Hypertension, Renal; Isoproterenol; Male; Muscle Contraction; Nitroglycerin; Rats; Rats, Inbred Strains; Serotonin; Vasomotor System | 1976 |
Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Animals; Antimetabolites; Aorta, Thoracic; Bucladesine; Deoxyglucose; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Rabbits; Rats; Rats, Inbred Strains; Rotenone; Vasodilation; Verapamil | 1991 |
Pharmacological regulation of the circulation of bone.
Topics: Acetylcholine; Animals; Atropine; Bone and Bones; Bucladesine; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Isoproterenol; Methoxamine; Nitroglycerin; Peptides; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Receptors, Drug; Regional Blood Flow; Tibia; Vasoconstrictor Agents; Vasodilator Agents | 1990 |
Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Acetylcholine; Aging; Bucladesine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Iodocyanopindolol; Isoproterenol; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Pindolol; Receptors, Adrenergic, beta; Serotonin | 1986 |
Nitroglycerine- and isoprenaline-induced vasodilatation: assessment from the actions of cyclic nucleotides.
Topics: Animals; Bucladesine; Caffeine; Calcium; Cyclic AMP; Cyclic GMP; Drug Interactions; Female; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Proteins; Muscle, Smooth, Vascular; Nitroglycerin; Norepinephrine; Potassium; Protein Kinases; Rabbits; Swine; Vasodilation | 1985 |
Age-related changes in vascular responsiveness to cyclic nucleotides and contractile agonists.
Topics: Aging; Animals; Aorta, Thoracic; Benzyl Compounds; Bucladesine; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Ethers; Imidazoles; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Nitrites; Nitroglycerin; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Potassium Chloride; Rats; Serotonin; Vasoconstrictor Agents | 1974 |
Effects of interleukin-1 beta and nitric oxide on cardiac myocytes.
Topics: Animals; Atrial Natriuretic Factor; Brain-Derived Neurotrophic Factor; Bucladesine; Cells, Cultured; Cyclic GMP; Heart; Interleukin-1; Myocardium; Nerve Tissue Proteins; Nitric Oxide; Nitroglycerin; Phenylephrine; Proteins; Rats; RNA, Messenger; Transcription Factor AP-1 | 1995 |
Synergistic effects of cyclic AMP-related vasodilators and the phosphatase inhibitor okadaic acid.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Bucladesine; Colforsin; Drug Synergism; Ethers, Cyclic; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Nitroglycerin; Nitroprusside; Okadaic Acid; Phosphoprotein Phosphatases; Potassium; Rats; Rats, Wistar; Vasodilator Agents; Verapamil | 1993 |
Effects of physostigmine and some nitric oxide-cyclic GMP-related compounds on muscarinic receptor-mediated autoinhibition of hippocampal acetylcholine release.
Topics: Acetylcholine; Animals; Arginine; Atropine; Bucladesine; Cyclic GMP; Dibutyryl Cyclic GMP; Electric Stimulation; Hippocampus; In Vitro Techniques; Kinetics; Male; Nitric Oxide; Nitroarginine; Nitroglycerin; Nitroprusside; Physostigmine; Rats; Rats, Wistar; Receptors, Muscarinic | 1993 |
Effective 30-hour preservation of canine lungs with modified ET-Kyoto solution.
Topics: Acetylcysteine; Adenosine; Allopurinol; Animals; Bucladesine; Dogs; Drug Evaluation, Preclinical; Ethanol; Gluconates; Glutathione; Hydroxyethyl Starch Derivatives; Insulin; Lung; Lung Transplantation; Nitroglycerin; Organ Preservation; Organ Preservation Solutions; Phosphates; Propylene Glycol; Propylene Glycols; Raffinose; Random Allocation; Reperfusion; Solutions; Time Factors; Trehalose | 1996 |
New ET-Kyoto solution containing N-acetylcysteine, nitroglycerin, and dibutyryl cyclic AMP provides reliable 30-hour canine lung preservation.
Topics: Acetylcysteine; Adenosine; Allopurinol; Analysis of Variance; Animals; Bucladesine; Dogs; Endothelium, Vascular; Gluconates; Glutathione; Hydroxyethyl Starch Derivatives; Insulin; Ischemia; Lung; Lung Transplantation; Microscopy, Electron, Scanning; Nitroglycerin; Organ Preservation; Organ Preservation Solutions; Oxygen; Phosphates; Raffinose; Time Factors; Trehalose | 1996 |
Effect of new ET-Kyoto solution on 17-hour lung preservation in isolated rat lungs.
Topics: Acetylcysteine; Analysis of Variance; Animals; Bucladesine; Gluconates; Hydroxyethyl Starch Derivatives; Lung; Male; Nitroglycerin; Organ Preservation; Phosphates; Rats; Rats, Inbred Lew; Reperfusion; Respiratory Function Tests; Trehalose | 1996 |
Selective effect of high arterial pressure in hypertension upon inhibition of cGMP versus cAMP mediated vascular relaxation.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Blood Pressure; Bucladesine; Cyclic AMP; Cyclic GMP; Hypertension, Renovascular; In Vitro Techniques; Isoproterenol; Nitric Oxide; Nitroglycerin; Rats; Rats, Sprague-Dawley; Vasodilation | 1996 |
Effects of cAMP and cGMP on L-type calcium channel currents in rat mesenteric artery cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bucladesine; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Colforsin; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Nitroglycerin; Patch-Clamp Techniques; Rats; Rats, Wistar | 1997 |
Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion.
Topics: Adenosine Triphosphate; Animals; Bucladesine; Dogs; Lung; Lung Transplantation; Models, Animal; Nitroglycerin; Organ Preservation; Organ Preservation Solutions; Oxygen Consumption; Reperfusion; Reperfusion Injury; Time Factors; Tissue and Organ Harvesting; Warm Ischemia | 2012 |
Significant improvement in islet yield and survival with modified ET-Kyoto solution: ET-Kyoto/Neutrophil elastase inhibitor.
Topics: Acetylcysteine; Animals; Apoptosis; Bucladesine; Cell Survival; Gluconates; Hydroxyethyl Starch Derivatives; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Nitroglycerin; Proteinase Inhibitory Proteins, Secretory; Random Allocation; Trehalose | 2013 |
Comparison Between Modified Extracellular-Type Trehalose-Containing Kyoto Solution and University of Wisconsin Solution in 18-Hour Pancreas Preservation for Islet Transplantation.
Topics: Acetylcysteine; Adenosine; Allopurinol; Animals; Blood Glucose; Bucladesine; Diabetes Mellitus, Experimental; Female; Gluconates; Glutathione; Hydroxyethyl Starch Derivatives; Insulin; Islets of Langerhans Transplantation; Mice, Nude; Nitroglycerin; Organ Preservation; Organ Preservation Solutions; Pancreas; Raffinose; Reproducibility of Results; Swine; Transplantation, Heterologous; Trehalose | 2018 |